BOEUF (Bonesupport Holding AB) Moat Score: 4/10 (As of Jun. 28, 2026)


BOEUF Bonesupport Holding AB BOEUF
77 GF Score
Price $21.40
GF Value $44.05
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Moat Score?

Bonesupport Holding AB BOEUF 77 Moat Score is 4 as of Jun. 28, 2026. GuruFocus rates BOEUF with a GF Score™ of 77/100 and a GF Value™ of $44.05 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 847 Medical Devices & Instruments companies, Bonesupport Holding AB ranks better than 83.23% on this metric.

Bonesupport Holding AB has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Bonesupport Holding AB has Narrow Moat: Bonesupport Holding AB has a discernible but modest moat due to its valuable intellectual property in bone graft substitutes. However, it faces competition from larger medical device companies, limiting its market leadership and pricing power.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Bonesupport Holding AB might have Narrow Moat - Discernible but modest moat.

Bonesupport Holding AB  (OTCPK:BOEUF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Bonesupport Holding AB Moat Score Related Terms

BOEUF vs ISRG, BDX, MDLN: Moat Score Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bonesupport Holding AB Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Moat Score distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's Moat Score falls into.


BOEUF
77GF Score
Bonesupport Holding AB BOEUF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Bonesupport Holding AB (BOEUF) has a Moat Score of 4 as of Jun. 28, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Bonesupport Holding AB ranks #142 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 16.8%.
Is Bonesupport Holding AB's Moat Score too high?
Bonesupport Holding AB's current Moat Score is 4. Based on the distribution chart, Bonesupport Holding AB ranks #142 out of 847 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonesupport Holding AB has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's Moat Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonesupport Holding AB ranks #142 out of 847 companies for Moat Score. This places Bonesupport Holding AB in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Bonesupport Holding AB's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (BOEUF) is currently considered Significantly Undervalued. The stock's GF Value™ is $44.05, compared to a current price of $21.40 — trading 51.4% below its estimated fair value. The current Moat Score is 4. Bonesupport Holding AB's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Bonesupport Holding AB (BOEUF), the current Moat Score is 4 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonesupport Holding AB (BOEUF) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of $21.40 is trading 51.4% below its estimated GF Value™ of $44.05. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for BOEUF:

  • Moat Score: 4
  • GF Value™: $44.05 vs. price of $21.40 (51.4% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the BOEUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
77GF Score

Get the complete analysis for BOEUF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.40
Price
$44.05
GF Value